A Comprehensive Review of Inflammatory Bowel Disease Focusing on Surgical Management

다국어 초록 (Multilingual Abstract)

The two main diseases of inflammatory bowel disease are Crohn’s disease and ulcerative colitis. The pathogenesis of inflammatory disease is that abnormal intestinal inflammations occur in genetically susceptible individuals according to various environmental factors. The consequent process results in inflammatory bowel disease. Medical treatment consists of the induction of remission in the acute phase of the disease and the maintenance of remission. Patients with Crohn’s disease finally need surgical treatment in 70% of the cases. The main surgical options for Crohn’s disease are divided into two surgical procedures. The first is strictureplasty, which can prevent short bowel syndrome. The second is resection of the involved intestinal segment. Simultaneous medico-surgical treatment can be a good treatment strategy. Ulcerative colitis is a diffuse nonspecific inflammatory disease that involves the colon and the rectum. Patients with ulcerative colitis need surgical treatment in 30% of the cases despite proper medical treatment. The reasons for surgical treatment are various,from life-threatening complications to growth retardation. The total proctocolectomy (TPC) with an ileal pouch anal anastomosis (IPAA) is the most common procedure for the surgical treatment of ulcerative colitis. Medical treatment for ulcerative colitis after a TPC with an IPAA is usually not necessary.

참고문헌 (Reference)

1 김덕환, "크론병과 연관된 복강 내 농양에서 비수술 치료의 효용성" 대한소화기학회 53 (53): 29-35, 2009

2 Crohn BB, "pathologic and clinical entity" 99 : 1323-1329, 1932

3 Heyen F, "Vaginal fistulas in Crohn’s disease" 32 : 379-383, 1989

4 Lee PY, "Vaginal fistula following restorative proctocolectomy" 40 : 752-759, 1997

5 Schneider MU, "Treatment of Crohn’s disease with metronidazole (author’s transl)" 106 : 1126-1129, 1981

6 Utsunomiya J, "Total colectomy, mucosal proctectomy, and ileoanal anastomosis" 23 : 459-466, 1980

7 Cima RR, "Timing and indications for colectomy in chronic ulcerative colitis: surgical consideration" 28 : 501-507, 2010

8 Joossens S, "The value of serologic markers in indeterminate colitis: a prospective follow-up study" 122 : 1242-1247, 2002

9 Eaden JA, "The risk of colorectal cancer in ulcerative colitis: a meta-analysis" 48 : 526-535, 2001

10 Brooke BN, "The management of an ileostomy, including itscomplications" 2 : 102-104, 1952

11 Farmer M, "The importance of diagnostic accuracy in colonic inflammatory bowel disease" 95 : 3184-3188, 2000

12 Koltun WA, "The future of surgical management of inflammatory bowel disease" 51 : 813-817, 2008

13 Ekbom A, "The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden" 100 : 350-358, 1991

14 Loftus EV Jr, "The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review" 16 : 51-60, 2002

15 Oresland T, "The clinical and functional outcome after restorative proctocolectomy. A prospective study in 100 patients" 4 : 50-56, 1989

16 Sandborn WJ, "Tacrolimus for the treatment of fistulas in patients with Crohn’s disease: a randomized, placebo-controlled trial" 125 : 380-388, 2003

17 Cellini C, "Surgical management of pyogenic complications of Crohn’s disease" 16 : 512-517, 2010

18 Shaffer VO, "Surgical management of Crohn’s disease. Langenbecks Arch Surg"

19 Spinelli A, "Surgical approach to ulcerative colitis: when is the best timing after medical treatment?" 12 : 1462-1466, 2011

20 Wolkomir AF, "Surgery for symptomatic hemorrhoids and anal fissures in Crohn’s disease" 36 : 545-547, 1993

21 Sugita A, "Surgery for Crohn’s anal fistulas" 30 : 1995

22 Roy P, "Strictureplasty for active Crohn’s disease" 21 : 427-432, 2006

23 Roy P, "Strictureplasty" 91 : 1428-1437, 2004

24 Jobanputra S, "Strictureplasty" 20 : 294-302, 2007

25 Katariya RN, "Stricture-plasty for tubercular strictures of the gastro-intestinal tract" 64 : 496-498, 1977

26 Damgaard B, "Social and sexual function following ileal pouch-anal anastomosis" 38 : 286-289, 1995

27 Zimmerman DD, "Smoking affects the outcome of transanal mucosal advancement flap repair of trans-sphincteric fistulas" 90 : 351-354, 2003

28 Blanchard JF, "Small-area variations and sociodemographic correlates for the incidence of Crohn’s disease and ulcerative colitis" 154 : 328-335, 2001

29 Rijcken E, "Single-incision laparoscopic surgery for ileocolic resection in Crohn’s disease" 55 : 140-146, 2012

30 Williams JG, "Seton treatment of high anal fistulae" 78 : 1159-1161, 1991

31 Chapman-Kiddell CA, "Role of diet in the development of inflammatory bowel disease" 16 : 137-151, 2010

32 Devroede G, "Risk of cancer in inflammatory bowel disease, In Colorectal cancer: prevention, epidemiology and screening" Paven Press 325-334, 1980

33 Bernell O, "Risk factors for surgery and postoperative recurrence in Crohn’s disease" 231 : 38-45, 2000

34 Bell SJ, "Response of fistulating Crohn’s disease to infliximab treatment assessed by magnetic resonance imaging" 17 : 387-393, 2003

35 Cintron JR, "Repair of fistulas-in-ano using fibrin adhesive: long-term follow- up" 43 : 944-949, 2000

36 Park JJ, "Repair of chronic anorectal fistulae using commercial fibrin sealant" 135 : 166-169, 2000

37 Hanauer SB, "Rapid closure of Crohn’s disease fistulas with continuous intravenous cyclosporin A" 88 : 646-649, 1993

38 Heikens JT, "Quality of life and health status before and after ileal pouch-anal anastomosis for ulcerative colitis" 99 : 263-269, 2012

39 Milsom JW, "Prospective, randomized trial comparing laparoscopic vs. conventional surgery for refractory ileocolic Crohn’s disease" 44 : 1-8, 2001

40 Parks AG, "Proctocolectomy without ileostomy for ulcerative colitis" 2 : 85-88, 1978

41 Bush A, "Primary biliary cirrhosis and ulcerative colitis" 92 : 2009-2013, 1987

42 Paye F, "Pouchrelated fistula following restorative proctocolectomy" 83 : 1574-1577, 1996

43 Mignon M, "Pouchitis: a poorly understood entity" 38 : 100-103, 1995

44 Stahlberg D, "Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors" 39 : 1012-1018, 1996

45 Macafee DA, "Pouchitis" 6 : 142-152, 2004

46 O’Kelly TJ, "Pouch-vaginal fistula after restorative proctocolectomy: aetiology and management" 81 : 1374-1375, 1994

47 Groom JS, "Pouch-vaginal fistula" 80 : 936-940, 1993

48 West RL, "Perianal fistulas in Crohn’s disease are predominantly colonized by skin flora: implications for antibiotic treatment?" 50 : 1260-1263, 2005

49 McKee RF, "Perianal Crohn’s disease: is it all bad news?" 39 : 136-142, 1996

50 Singh B, "Perianal Crohn’s disease" 91 : 801-814, 2004

51 Sahai A, "Percutaneous drainage of intra-abdominal abscesses in Crohn’s disease: short and long-term outcome" 92 : 275-278, 1997

52 Lambiase RE, "Percutaneous drainage of abscesses in patients with Crohn disease" 150 : 1043-1045, 1988

53 Poritz LS, "Percutaneous drainage and ileocolectomy for spontaneous intraabdominal abscess in Crohn’s disease" 11 : 204-208, 2007

54 Safrit HD, "Percutaneous abscess drainage in Crohn’s disease" 148 : 859-862, 1987

55 Gervais DA, "Percutaneous abscess drainage in Crohn disease: technical success and shortand long-term outcomes during 14 years" 222 : 645-651, 2002

56 Sonoda T, "Outcomes of primary repair of anorectal and rectovaginal fistulas using the endorectal advancement flap" 45 : 1622-1628, 2002

57 Gaetini A, "Our experience with strictureplasty in the surgical treatment of Crohn’s disease" 36 : 511-515, 1989

58 Williamson ME, "One-stage restorative proctocolectomy without temporary ileostomy for ulcerative colitis: a note of caution" 40 : 1019-1022, 1997

59 Tjandra JJ, "Omission of temporary diversion in restorative proctocolectomy: is it safe?" 36 : 1007-1014, 1993

60 Laureti S, "Obstruction in Crohn’s disease: strictureplasty versus resection" 3 : 191-202, 2000

61 Holubar SD, "Minimally invasive subtotal colectomy and ileal pouch-anal anastomosis for fulminant ulcerative colitis: a reasonable approach?" 52 : 187-192, 2009

62 Lee EC, "Minimal surgery for chronic obstruction in patients with extensive or universal Crohn’s disease" 64 : 229-233, 1982

63 Brandt LJ, "Metronidazole therapy for perineal Crohn’s disease: a follow-up study" 83 : 383-387, 1982

64 Jakobovits J, "Metronidazole therapy for Crohn’s disease and associated fistulae" 79 : 533-540, 1984

65 Schneider MU, "Metronidazole in the treatment of Crohn disease. Results of a controlled randomized prospective study" 110 : 1724-1730, 1985

66 Allan A, "Management of perianal Crohn’s disease" 12 : 198-202, 1988

67 Ayuk P, "Management of intra-abdominal abscesses in Crohn’s disease" 78 : 5-10, 1996

68 Shah NS, "Management and treatment outcome of pouch-vaginal fistulas following restorative proctocolectomy" 46 : 911-917, 2003

69 Heriot AG, "Management and outcome of pouch-vaginal fistulas following restorative proctocolectomy" 48 : 451-458, 2005

70 Hanauer SB, "Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial" 359 : 1541-1549, 2002

71 Morris J, "MR imaging classification of perianal fistulas and its implications for patient management" 20 : 623-635, 2000

72 Faucheron JL, "Long-term seton drainage for high anal fistulas in Crohn’s disease: a sphinctersaving operation?" 39 : 208-211, 1996

73 Vitton V, "Long-term healing of Crohn’s anal fistulas with fibrin glue injection" 21 : 1453-1457, 2005

74 Guadalajara H, "Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas" 27 : 595-600, 2012

75 Uchino M, "Long-term efficacy of strictureplasty for Crohn’s disease" 40 : 949-953, 2010

76 Maartense S, "Laparoscopic-assisted versus open ileocolic resection for Crohn’s disease: a randomized trial" 243 : 143-149, 2006

77 Nguyen SQ, "Laparoscopic resection for Crohn’s disease: an experience with 335 cases" 23 : 2380-2384, 2009

78 Bergamaschi R, "Laparoscopic intracorporeal ileocolic resection for Crohn’s disease: is it safe?" 52 : 651-656, 2009

79 Peppercorn MA, "Is there a role for antibiotics as primary therapy in Crohn’s ileitis?" 17 : 235-237, 1993

80 Nagler SM, "Intraabdominal abscess in regional enteritis" 137 : 350-354, 1979

81 Kock NG, "Intra-abdominal “reservoir” in patients with permanent ileostomy. Preliminary observations on a procedure resulting in fecal “continence” in five ileostomy patients" 99 : 223-231, 1969

82 Jawhari A, "Intra-abdominal and pelvic abscess in Crohn’s disease: results of noninvasive and surgical management" 85 : 367-371, 1998

83 Present DH, "Infliximab for the treatment of fistulas in patients with Crohn’s disease" 340 : 1398-1405, 1999

84 Rutgeerts P, "Infliximab for induction and maintenance therapy for ulcerative colitis" 353 : 2462-2476, 2005

85 Kodner IJ, "Inflammatory bowel disease" 34 : 3-32, 1982

86 Tonelli F, "Indications and results of side-to-side isoperistaltic strictureplasty in Crohn’s disease" 47 : 494-501, 2004

87 Burakoff R, "Indeterminate colitis: clinical spectrum of disease" 38 : 41-43, 2004

88 Yang SK, "Incidence and prevalence of ulcerative colitis in the Songpa- Kangdong District, Seoul, Korea, 1986-1997" 15 : 1037-1042, 2000

89 Keighley MR, "Incidence and microbiology of abdominal and pelvic abscess in Crohn’s disease" 83 : 1271-1275, 1982

90 Nivatvongs S, "In: Gordon PH, Nivatvongs S, editors. Principles and practice of surgery for the colon, rectum and anus. 2nd ed" Quality Medical 907-974, 1999

91 Hawley PR, "Ileorectal anastomosis" 72 : 75-76, 1985

92 Dozois RR, "Ileal pouch-anal anastomosis: comparison of results in familial adenomatous polyposis and chronic ulcerative colitis" 210 : 268-271, 1989

93 Galandiuk S, "Ileal pouch-anal anastomosis. Reoperation for pouch-related complications" 212 : 446-452, 1990

94 Yu CS, "Ileal pouch-anal anastomosis in patients with indeterminate colitis: long-term results" 43 : 1487-1496, 2000

95 Fazio VW, "Ileal pouch-anal anastomoses complications and function in 1005 patients" 222 : 120-127, 1995

96 Wexner SD, "Ileal pouch vaginal fistulas: incidence, etiology, and management" 32 : 460-465, 1989

97 Eade MN, "Hepatobiliary disease associated with ulcerative colitis" 53 : 112-118, 1973

98 Lupinetti M, "Hepatobiliary complications of ulcerative colitis" 139 : 113-118, 1980

99 Bernstein LH, "Healing of perineal Crohn’s disease with metronidazole" 79 : 357-365, 1980

100 Vernava AM, "Goldberg SM. Is the Kock pouch still a viable option?" 3 : 135-138, 1988

101 Sonnenberg A, "Geographic variation of inflammatory bowel disease within the United States" 100 : 143-149, 1991

102 Wellcome Trust Case Control Consortium, "Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls" 447 : 661-678, 2007

103 Lees CW, "Genetics of inflammatory bowel disease:implications for disease pathogenesis and natural history" 3 : 513-534, 2009

104 Kirat HT, "Finney and Jaboulay techniques, In Colon and rectal surgery: abdominal operations" Lippincott Williams & Wilkins 563-579, 2012

105 Patrlj L, "Fibrin glue-antibiotic mixture in the treatment of anal fistulae: experience with 69 cases" 17 : 77-80, 2000

106 Loungnarath R, "Fibrin glue treatment of complex anal fistulas has low success rate" 47 : 432-436, 2004

107 Sentovich SM, "Fibrin glue for all anal fistulas" 5 : 158-161, 2001

108 Venkatesh KS, "Fibrin glue application in the treatment of recurrent anorectal fistulas" 42 : 1136-1139, 1999

109 Hjortrup A, "Fibrin adhesive in the treatment of perineal fistulas" 34 : 752-754, 1991

110 Levine JB, "Extraintestinal considerations in inflammatory bowel disease" 24 : 633-646, 1995

111 Garcia-Olmo D, "Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial" 52 : 79-86, 2009

112 Gustafsson UM, "Excision of anal fistula with closure of the internal opening: functional and manometric results" 45 : 1672-1678, 2002

113 Marcello PW, "Evolutionary changes in the pathologic diagnosis after the ileoanal pouch procedure" 40 : 263-269, 1997

114 de la Portilla F, "Evaluation of the use of BioGlue in the treatment of high anal fistulas: preliminary results of a pilot study" 50 : 218-222, 2007

115 Montgomery SM, "Epidemiology of inflammatory bowel disease" 18 : 416-420, 2002

116 Ortiz H, "Endorectal flap advancement repair and fistulectomy for high trans-sphincteric and suprasphincteric fistulas" 87 : 1680-1683, 2000

117 Mizrahi N, "Endorectal advancement flap: are there predictors of failure?" 45 : 1616-1621, 2002

118 Kodner IJ, "Endorectal advancement flap repair of rectovaginal and other complicated anorectal fistulas" 114 : 682-689, 1993

119 Johnson EK, "Efficacy of anal fistula plug vs. fibrin glue in closure of anorectal fistulas" 49 : 371-376, 2006

120 Cangemi JR, "Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis" 96 : 790-794, 1989

121 Lawes DA, "Early experience with the bioabsorbable anal fistula plug" 32 : 1157-1159, 2008

122 Fenoglio CMRiddell RH, "Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications" 14 : 931-968, 1983

123 Kent TH, "Differentiation of ulcerative colitis and regional enteritis of colon" 89 : 20-29, 1970

124 Schwartz DA, "Diagnosis and treatment of perianal fistulas in Crohn disease" 135 : 906-918, 2001

125 Lichtiger S, "Cyclosporine in severe ulcerative colitis refractory to steroid therapy" 330 : 1841-1845, 1994

126 Dietz DW, "Crohn’s anorectal disease, In Operative strategies in inflammatory bowel disease" Springer 394-408, 1999

127 Langholz E, "Course of ulcerative colitis: analysis of changes in disease activity over years" 107 : 3-11, 1994

128 Truelove SC, "Cortisone in ulcerative colitis; preliminary report on a therapeutic trial" 2 : 375-378, 1954

129 Truelove SC, "Cortisone in ulcerative colitis; final report on a therapeutic trial" 2 : 1041-1048, 1955

130 Bernini A, "Computed tomography-guided percutane ous abscess drainage in intestinal disease: factors associated with outcome" 40 : 1009-1013, 1997

131 Shaker MA, "Competent closure of chronic oroantral fistula with Zenoderm" 41 : 1237-1242, 1995

132 Harpaz N, "Colorectal dysplasia in chronic inflammatory bowel disease: pathology, clinical implications, and pathogenesis" 134 : 876-895, 2010

133 Hughes LE, "Clinical classification of perianal Crohn’s disease" 35 : 928-932, 1992

134 Schoetz DJ Jr, "Can the pouch be saved?" 31 : 671-675, 1988

135 Ellis CN, "Bioprosthetic plugs for complex anal fistulas: an early experience" 64 : 36-40, 2007

136 Abel ME, "Autologous fibrin glue in the treatment of rectovaginal and complex fistulas" 36 : 447-449, 1993

137 Duepree HJ, "Advantages of laparoscopic resection for ileocecal Crohn’s disease" 45 : 605-610, 2002

138 Garcia JC, "Abscesses in Crohn’s disease: outcome of medical versus surgical treatment" 32 : 409-412, 2001

139 Neufeld D, "Abdominal wall abscesses in patients with Crohn’s disease: clinical outcome" 10 : 445-449, 2006

140 Combe C, "A singular case of stricture and thickening of the ileum" 16-18, 1806

141 Targan SR, "A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn’s disease. Crohn’s Disease cA2 Study Group" 337 : 1029-1035, 1997

142 Lindsey I, "A randomized, controlled trial of fibrin glue vs. conventional treatment for anal fistula" 45 : 1608-1615, 2002

143 Duerr RH, "A genome-wide association study identifies IL23R as an inflammatory bowel disease gene" 314 : 1461-1463, 2006

144 Ogura Y, "A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease" 411 : 603-606, 2001

145 Colombel JF, "A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn’s disease. Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives (GETAID)" 94 : 674-678, 1999

146 Ambe R, "A comprehensive review of strictureplasty techniques in Crohn’s disease: types, indications, comparisons, and safety" 16 : 209-217, 2012